Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reported the vesting of restricted stock units and subsequent acquisition of common stock in Guardant Health, Inc.
Summary
- On May 31, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- Specifically, 155 restricted stock units vested, converting into 155 shares of common stock.
- The price per share for the conversion was $0.
- Following the transaction, Krognes directly owns 3,548 shares of common stock and 3,857 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company leadership.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 08/09/2022 | Date of restricted stock unit award grant. |
| 06/30/2023 | First vesting date of the restricted stock unit award (25%). |
| 05/31/2024 | Date of the reported transaction: vesting of 155 restricted stock units and acquisition of 155 shares of common stock. |
| 06/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.